|
|
| | 5-(6-Hydroxybenzofuran-2-yl)-2-(3-methyl-2-butenyl)-1,3-benzenediol Basic information |
| Product Name: | 5-(6-Hydroxybenzofuran-2-yl)-2-(3-methyl-2-butenyl)-1,3-benzenediol | | Synonyms: | 5-(6-Hydroxybenzofuran-2-yl)-2-(3-methyl-2-butenyl)-1,3-benzenediol;Moracin C;5-(6-Hydroxy-2-benzofuranyl)-2-(3-methyl-2-butenyl)-1,3-benzenediol;1,3-Benzenediol, 5-(6-hydroxy-2-benzofuranyl)-2-(3-methyl-2-buten-1-yl)-;5-(6-hydroxy-1-benzofuran-2-yl)-2-(3-methylbut-2-enyl)benzene-1,3-diol | | CAS: | 69120-06-5 | | MF: | C19H18O4 | | MW: | 310.34 | | EINECS: | | | Product Categories: | | | Mol File: | 69120-06-5.mol |  |
| | 5-(6-Hydroxybenzofuran-2-yl)-2-(3-methyl-2-butenyl)-1,3-benzenediol Chemical Properties |
| Boiling point | 439.4±35.0 °C(Predicted) | | density | 1.278±0.06 g/cm3(Predicted) | | solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | | form | Powder | | pka | 9.08±0.40(Predicted) |
| | 5-(6-Hydroxybenzofuran-2-yl)-2-(3-methyl-2-butenyl)-1,3-benzenediol Usage And Synthesis |
| Uses | Moracin C is used as a diabetic medication and also used in other drug development. An inhibitor of Staphylococcus aureus enoyl-acyl carrier protein reductase from Morus alba leaf. | | Definition | ChEBI: Moracin C is a member of benzofurans. | | target | ROS | NOS | COX | TNF-α | IL Receptor | NO | NF-kB | ERK | JNK | p38MAPK | Antifection | c-Myc |
| | 5-(6-Hydroxybenzofuran-2-yl)-2-(3-methyl-2-butenyl)-1,3-benzenediol Preparation Products And Raw materials |
|